We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Tablet and granules
Indication
For the treatment of cystic fibrosis
Therapeutic area
Respiratory